A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis Meeting Abstract


Authors: Gounder, M. M.; Zer, A.; Tap, W. D.; Gupta, A. A.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Tanner, L. R.; Konen, T.; Rashal, T.; McCauley, D.; Saint-Martin, J. R.; Carlson, R.; Marshall, T.; Shacham, S.; Mirza, M. R.; Kauffman, M.; Schwartz, G.; Razak, A. R. A.
Abstract Title: A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036900209
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.10569
Notes: Meeting Abstract: 10569 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ping Chi
    173 Chi
  2. Mary Louise Keohan
    125 Keohan
  3. Mrinal M Gounder
    229 Gounder
  4. Sandra Pierina D'Angelo
    253 D'Angelo
  5. Mark Andrew Dickson
    170 Dickson
  6. William Douglas Tap
    374 Tap
  7. Lanier R Tanner
    4 Tanner